
LENZ Therapeutics, Inc.
USD5.16
+0.20 (+4.03%)
CEO
Evert Schimmelpennink
IPO Date
2021-06-25
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$4.91
Prev. Close
$4.96
Day Low
$4.91
Day High
$5.16
52W Low
$4.68
52W High
$50.40
Market Cap
$0.16B
Volume
0.73M
| 12 May 2026 |
| Piper Sandler |
| Overweight |
| Neutral |
| downgrade |
| 21 Apr 2026 | HC Wainwright & Co. | Buy | Buy | maintain |
| 26 Mar 2026 | Citigroup | Buy | Buy | maintain |
| 25 Mar 2026 | B of A Securities | Buy | Buy | maintain |
| 20 Oct 2025 | Raymond James | Outperform | Outperform | maintain |
| 10 Oct 2025 | Piper Sandler | Overweight | Overweight | maintain |
| 1 Aug 2025 | HC Wainwright & Co. | Buy | Buy | maintain |